Literature DB >> 28124112

Is there room for behavioral and modifiable health-related targets in the lower urinary tract symptoms' scenario.

Osamu Ikari1, Brunno C F Sanches1, João Carlos Cardoso Alonso2, Fabiano A Simões2, Ronald F Rejowski2, Walker Wendel Laranja2, Leonardo O Reis3,4,5.   

Abstract

PURPOSE: To better understand potential modifiable risk factors guiding preventive interventions against lower urinary tract symptoms (LUTS).
METHODS: A prospective cross-sectional study, including healthy men aged 40-70 years under routine urological evaluation, measured the strength of association between the International Prostate Symptom Score (IPSS) and socio-demographic, lifestyle, and health-related factors using logistic and linear regression adjusted for confounding factors. Men with urethral or prostate surgery were excluded.
RESULTS: Among 743 men, mean age 59.64 ± 9.66, 22.6% reported moderate, and 5.0% severe LUTS. The adjusted odds of severe LUTS increased with: increasing age (OR = 1.07, 95% CI = 1.05-1.09, p < .0001), increasing prostate volume (OR = 1.02, 95% CI = 1.01-1.04, p = .004), decreasing education (tertiary qualification, no versus yes, OR = 2.34; 95% CI = 1.16-4.70; p = .0133), delayed ejaculation (yes versus no, OR = 2.63, 95% CI = 1.43-4.83, p < .0001), and increasing blood pressure (systolic ≥130 mmHg, OR = 2.03, 95% CI = 1.44-2.86, p < .0001 or diastolic ≥85 mmHg, OR = 1.47, 95% CI = 1.03-2.10, p = .0345); severe LUTS decreased with: increasing the weekly sexual frequency (OR = 0.80, 95% CI = 0.69-0.91, p = .0012) and increasing HDL cholesterol (OR = 0.98, 95% CI = 0.97-0.99, p = .037). Odds were not significant for age of sexual initiation, precocious ejaculation, masturbatory pattern, physical activity, smoking, alcohol consumption, penile length (objective and subjective), abdominal circumference, obesity, comorbid conditions, metabolic syndrome, serum glycaemia, testosterone, SHBG, PSA, and estradiol.
CONCLUSIONS: One in every four men under routine urological evaluation who considered themselves healthy present moderate and severe LUTS. Modifiable behavioral (education, sexual frequency, and ejaculation) and health-related (blood pressure and HDL cholesterol) targets were identified for future interventional studies and potential preventive actions and patient counseling.

Entities:  

Keywords:  Chronic pelvic ischemia syndrome; IPSS; Risk factor; Voiding

Mesh:

Substances:

Year:  2017        PMID: 28124112     DOI: 10.1007/s00345-016-1999-8

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  22 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

2.  The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association.

Authors:  M J Barry; F J Fowler; M P O'Leary; R C Bruskewitz; H L Holtgrewe; W K Mebust; A T Cockett
Journal:  J Urol       Date:  1992-11       Impact factor: 7.450

3.  Association between socioeconomic status (SES) and lower urinary tract symptom (LUTS) severity among black and white men.

Authors:  Jay H Fowke; Heather Munro; Lisa B Signorello; William J Blot; David F Penson
Journal:  J Gen Intern Med       Date:  2011-07-01       Impact factor: 5.128

Review 4.  Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome.

Authors:  Linda Vignozzi; Mauro Gacci; Mario Maggi
Journal:  Nat Rev Urol       Date:  2016-01-12       Impact factor: 14.432

5.  Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction.

Authors:  Debra E Irwin; Zoe S Kopp; Barnabie Agatep; Ian Milsom; Paul Abrams
Journal:  BJU Int       Date:  2011-01-13       Impact factor: 5.588

6.  The Relationship between the Clinical Progression of Benign Prostatic Hyperplasia and Metabolic Syndrome: A Prospective Study.

Authors:  Yongqiang Fu; Zhe Zhou; Bing Yang; Kai Zhang; Lijun He; Xianghua Zhang
Journal:  Urol Int       Date:  2016-08-11       Impact factor: 2.089

7.  Association of lower urinary tract symptoms and chronic ischaemia of the lower urinary tract in elderly women and men: assessment using colour Doppler ultrasonography.

Authors:  Germar-Michael Pinggera; Michael Mitterberger; Eberhard Steiner; Leo Pallwein; Ferdinand Frauscher; Friedrich Aigner; Georg Bartsch; Hannes Strasser
Journal:  BJU Int       Date:  2008-05-12       Impact factor: 5.588

8.  Men with Hypertension are More Likely to Have Severe Lower Urinary Tract Symptoms and Large Prostate Volume.

Authors:  Eu Chang Hwang; Sun-Ouck Kim; Deok-Hyun Nam; Ho Song Yu; Insang Hwang; Seung Il Jung; Taek Won Kang; Dong Deuk Kwon; Geun Soo Kim
Journal:  Low Urin Tract Symptoms       Date:  2013-12-23       Impact factor: 1.592

9.  Lower Urinary Tract Symptoms are Associated with Erectile Function and Psychological Symptoms in Men with Late-Onset Hypogonadism Syndrome.

Authors:  Kazuyoshi Shigehara; Kazuhiro Sugimoto; Hiroyuki Konaka; Yuji Maeda; Yasuhide Kitagawa; Atsushi Mizokami; Eitetsu Koh; Mikio Namiki
Journal:  Low Urin Tract Symptoms       Date:  2013-09-16       Impact factor: 1.592

10.  IL-1 induces IGF-dependent epithelial proliferation in prostate development and reactive hyperplasia.

Authors:  Travis J Jerde; Wade Bushman
Journal:  Sci Signal       Date:  2009-09-01       Impact factor: 8.192

View more
  1 in total

1.  Correlation of tools for objective evaluation of infravesical obstruction of men with lower urinary tract symptoms.

Authors:  Orestes Mazzariol; Leonardo O Reis; Paulo R Palma
Journal:  Int Braz J Urol       Date:  2019 Jul-Aug       Impact factor: 1.541

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.